https://www.biospace.com/sqz-biotechnologies-reports-third-quarter-2023-financial-results-and-recent-portfolio-updates
SQZ Biotechnologies Company (OTC: SQZB), focused on unlocking the full potential of cell therapies, today reported third quarter 2023 financial results and...
third quartersqzbiotechnologiesreportsfinancial
https://www.biospace.com/roche-decides-not-to-exercise-solid-tumor-option-with-sqz
Embattled SQZ Biotechnologies announced Tuesday that the Swiss biotech will not exercise its option for HPV 16 positive solid tumors under the SQZ-APC-HPV...
not tosolid tumorrochedecidesexercise
https://www.fiercebiotech.com/biotech/difficult-necessary-steps-sqz-lays-80-staff-regenxbio-also-reduces-headcount
The most brutal cutbacks were at SQZ, which is letting go of fully 80% of its workforce as the cell therapy company seeks a long term survival plan.
sqzlaysstaffalsoreduces